BUZZ-Tevogen公司重申实验性肿瘤药物收入预期,公司业绩上涨

路透中文
29 Apr
BUZZ-Tevogen公司重申实验性肿瘤药物收入预期,公司业绩上涨

4月28日 - ** 药物开发商TevogenTVGN.O股价在盘后交易中上涨49.35%,报1.40美元

** 公司重申 (link) 其实验性肿瘤药物的最高收入预期

** 预计上市当年收入为 10 亿美元,5 年累计收入估计在 100 亿至 140 亿美元之间

** 股价年初至今下跌 9

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10